 Caitlin Costello
|
| Title(s) | Assistant Clinical Professor of Medicine, Medicine |
|---|
| School | Health Sciences |
|---|
| Address | 3855 Health Sciences Drive #0960
La Jolla CA 92093
|
|---|
| Phone | 858-822-6600 |
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | Harvard University | 2002 | | Cum Laude | | 2004 | | Robert J. Fahey Award for Compassion in Doctoring | | 2006 | | Worth F Bloom Award for High Standard of Excellence and Level of Compassion | | 2010
-
| 2012 | Akliviadis Vasiliadis Fellowship Award for Clinical Research | | 2011 | | American Society of Hematology Abstract Achievement Award | | 2012 | | American Society of Clinical Oncology Travel Award |
Overview Research Interests
As a member of the Division of Blood and Marrow Transplantation, Dr Costello is dedicated to providing excellent care for patients with a variety of hematologic malignancies, with a specific focus in lymphoproliferative disorders and bone marrow transplantation. Dr Costello’s research interests focus particularly on the refinement of the management and treatment of multiple myeloma. She is dedicated to conducting clinical trials with novel agents and treatment strategies to expand the therapeutic options for patients with multiple myeloma. As we enter the age of personalized medicine, Dr. Costello is principally interested in developing treatment strategies that are specific to the most finite genetic and molecular details of each individual patient’s disease.
Education and Training
BA - Biology, Harvard University, Cambridge, MA - 2002
MD - Medicine, Tufts University, School of Medicine, Boston, MA - 2006
Internship/Residency - Internal Medicine, New York Presbyterial/Weill Cornell Medical Center, New York, NY - 2006-2009
Fellowship - Hematology/Oncology, University of California, San Diego, CA - 2009-2012
ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
The future of checkpoint inhibition in multiple myeloma? Lancet Haematol. 2019 09; 6(9):e439-e440.
Costello C. PMID: 31327688.
View in: PubMed Mentions: 2 Fields: Translation: Humans
-
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results. Br J Haematol. 2018 03; 180(6):821-830.
Richardson PG, Bensinger WI, Huff CA, Costello CL, Lendvai N, Berdeja JG, Anderson LD, Siegel DS, Lebovic D, Jagannath S, Laubach JP, Stockerl-Goldstein KE, Kwei L, Clow F, Elias L, Salman Z, Graef T, Bilotti E, Vij R. PMID: 29435979.
View in: PubMed Mentions: 5 Fields: Translation: HumansCTClinical Trials
-
Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2015 Nov; 13(11):1398-435.
Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Singhal S, Smith C, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R. PMID: 26553768.
View in: PubMed Mentions: 14 Fields: Translation: Humans
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2015 | 1 | | 2018 | 1 | | 2019 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People who share similar concepts with this person.
_
Search Department
_
|